Skip to main content
Top
Published in: Abdominal Radiology 11/2019

Open Access 01-11-2019 | Magnetic Resonance Imaging | Special Section: Rectal Cancer

Prediction of efficacy of neoadjuvant chemoradiotherapy for rectal cancer: the value of texture analysis of magnetic resonance images

Authors: Zhenyu Shu, Songhua Fang, Qin Ye, Dewang Mao, Hongfeng Cao, Peipei Pang, Xiangyang Gong

Published in: Abdominal Radiology | Issue 11/2019

Login to get access

Abstract

Purpose

To explore the clinical feasibility of predicting the efficacy of neoadjuvant chemoradiotherapy (nCRT) for rectal cancer on the basis of texture analysis (TA) of T2-weighted imaging (T2WI).

Methods

The cohort for this prospective study comprised 136 patients with rectal cancer to be treated with nCRT, all of whom underwent three MR scans (pre-, early, and post-nCRT). Treatment efficacy was assessed on the basis of the outcomes of pathologic complete response (pCR) and non-pCR as determined by postoperative pathological examination. Extraction and analysis of texture features in T2WI of defined tumor regions were performed by AK software. Pre- and early-nCRT texture features were selected as potential predictors of outcomes by logistic regression analysis, and a prediction model for pCR was developed. A receiver operating characteristic (ROC) curve was used to assess the predictive power of texture features in pre- and early-nCRT images.

Results

Univariate logistic regression analysis demonstrated that the pre-nCRT features of energy, entropy, and skewness, and early-nCRT features of variance, kurtosis, energy, and entropy were independent predictors of pCR. A prediction model incorporating these predictors was constructed by multivariate logistic regression, The AUCs of pre-nCRT, early, and combined models were 0.751, 0.831, and 0.873, respectively; the sensitivities 66, 71, and 75%, respectively; and the specificities 87.22, 86.11, and 91.67%, respectively.

Conclusions

TA of T2WI images can predict the efficacy of nCRT for rectal cancer, possibly providing a new marker of tumor biological response in clinical practice.
Literature
1.
go back to reference Larsen IK, Bray F. Trends in colorectal cancer incidence in Norway 1962-2006: an interpretation of the temporal patterns by anatomic subsite. Int J Cancer, 2010, 126(3): 721-732CrossRef Larsen IK, Bray F. Trends in colorectal cancer incidence in Norway 1962-2006: an interpretation of the temporal patterns by anatomic subsite. Int J Cancer, 2010, 126(3): 721-732CrossRef
2.
go back to reference Sauer R, Liersch T, Merkel S, et al. Preoperative Versus Postoperative Chemoradiotherapy for Locally Advanced Rectal Cancer: Results of the German CAO/ARO/AIO-94 Randomized Phase III Trial After a Median Follow-Up of 11 Years. J Clin Oncol, 2012, 30(16): 1926-1933CrossRef Sauer R, Liersch T, Merkel S, et al. Preoperative Versus Postoperative Chemoradiotherapy for Locally Advanced Rectal Cancer: Results of the German CAO/ARO/AIO-94 Randomized Phase III Trial After a Median Follow-Up of 11 Years. J Clin Oncol, 2012, 30(16): 1926-1933CrossRef
3.
go back to reference O'Neill BD, Brown G, Heald RJ, et al. Non-operative treatment after neoadjuvant chemoradiotherapy for rectal cancer. Lancet Oncology. 2007,8(7): 625-633CrossRef O'Neill BD, Brown G, Heald RJ, et al. Non-operative treatment after neoadjuvant chemoradiotherapy for rectal cancer. Lancet Oncology. 2007,8(7): 625-633CrossRef
4.
go back to reference Rodel C, Liersch T, Becker H, et al. Preoperative chemoradiotherapy and postoperative chemotherapy with flurorouracil and oxaliplation versus fluorouracil alone in locally advanced rectal cancer: initial results of the German CAO/ARO/AIO-04 randomised phase 3 trial. LANCET ONCOL. 2012, 13(7): 679-687CrossRef Rodel C, Liersch T, Becker H, et al. Preoperative chemoradiotherapy and postoperative chemotherapy with flurorouracil and oxaliplation versus fluorouracil alone in locally advanced rectal cancer: initial results of the German CAO/ARO/AIO-04 randomised phase 3 trial. LANCET ONCOL. 2012, 13(7): 679-687CrossRef
5.
go back to reference Fernandez-Martos C, Pericay C, Aparicio J, et al. Phase II, randomized study of concomitant chemoradiotherapy followed by surgery and adjuvant capecitabine plus oxaliplatin (CAPOX) compared with induction CAPOX followed by concomitant chemoradiotherapy and surgery in magnetic resonance imaging-defined, locally advanced rectal cancer: Grupo cancer de recto 3 study. J Clin Oncol. 2010, 28(5): 859-865CrossRef Fernandez-Martos C, Pericay C, Aparicio J, et al. Phase II, randomized study of concomitant chemoradiotherapy followed by surgery and adjuvant capecitabine plus oxaliplatin (CAPOX) compared with induction CAPOX followed by concomitant chemoradiotherapy and surgery in magnetic resonance imaging-defined, locally advanced rectal cancer: Grupo cancer de recto 3 study. J Clin Oncol. 2010, 28(5): 859-865CrossRef
6.
go back to reference Lim JS, Kim D, Baek SE, et al. Perfusion MRI for the prediction of treatment response after preoperative chemoradiotherapy in locally advanced rectal cancer. Eur Radiol. 2012, 22(8): 1693-1700CrossRef Lim JS, Kim D, Baek SE, et al. Perfusion MRI for the prediction of treatment response after preoperative chemoradiotherapy in locally advanced rectal cancer. Eur Radiol. 2012, 22(8): 1693-1700CrossRef
7.
go back to reference Monguzzi L, Ippolito D, Bernasconi DP, et al. Locally advanced rectal cancer: value of ADC mapping in prediction of tumor response to radiochemotherapy. Eur J Radiol. 2013, 82(2): 234-240CrossRef Monguzzi L, Ippolito D, Bernasconi DP, et al. Locally advanced rectal cancer: value of ADC mapping in prediction of tumor response to radiochemotherapy. Eur J Radiol. 2013, 82(2): 234-240CrossRef
8.
go back to reference Battersby NJ, Balyasnikova S, Brown G. Guiding post-treatment decisions in rectal cancer: mrTRG is a practical place to start. Oncology(Williston Park). 2014, 28(8): 677-680 Battersby NJ, Balyasnikova S, Brown G. Guiding post-treatment decisions in rectal cancer: mrTRG is a practical place to start. Oncology(Williston Park). 2014, 28(8): 677-680
9.
go back to reference Garcia-Aguilar J, Pollack J, Lee SH, et al. Accuracy of endorectal ultrasonography in preoperative staging of rectal tumors. Dis Colon Rectum. 2002, 45 (1): 10-15CrossRef Garcia-Aguilar J, Pollack J, Lee SH, et al. Accuracy of endorectal ultrasonography in preoperative staging of rectal tumors. Dis Colon Rectum. 2002, 45 (1): 10-15CrossRef
10.
go back to reference Tylor FG, Quirke P, Heald RJ, et al. Preoperative high-resolution magnetic resonance imaging can identify good prognosis stage I, II, and III rectal cancer best managed by surgery alone: a prospective, multicenter, European study. Ann Surg. 2011, 253(4): 711-719CrossRef Tylor FG, Quirke P, Heald RJ, et al. Preoperative high-resolution magnetic resonance imaging can identify good prognosis stage I, II, and III rectal cancer best managed by surgery alone: a prospective, multicenter, European study. Ann Surg. 2011, 253(4): 711-719CrossRef
11.
go back to reference Orphanidou-Vlachou E, Vlachos N, Davies NP, et al. Texture analysis of T1-and T2-weighted MR images and use of probabilistic neural network to discriminate posterior fossa tumours in children[J]. NMR Biomed. 2014, 27(6): 632-639CrossRef Orphanidou-Vlachou E, Vlachos N, Davies NP, et al. Texture analysis of T1-and T2-weighted MR images and use of probabilistic neural network to discriminate posterior fossa tumours in children[J]. NMR Biomed. 2014, 27(6): 632-639CrossRef
12.
go back to reference Song I, Kim SH, Lee SJ, et al. Value of diffusion-weighted imaging in the detection of viable tumour after neoadjuvant chemoradiation therapy in patients with locally advanced rectal cancer: comparison with T2 weighted and PET/CT imaging. Br J Radiol. 2012, 85(1013): 577-586 Song I, Kim SH, Lee SJ, et al. Value of diffusion-weighted imaging in the detection of viable tumour after neoadjuvant chemoradiation therapy in patients with locally advanced rectal cancer: comparison with T2 weighted and PET/CT imaging. Br J Radiol. 2012, 85(1013): 577-586
13.
go back to reference Ganeshan B, Goh V, Mandeville HC, et al. Non-small cell lung cancer: histopathologic correlates for texture parameters at CT. Radiology. 2013, 266(1): 326-336CrossRef Ganeshan B, Goh V, Mandeville HC, et al. Non-small cell lung cancer: histopathologic correlates for texture parameters at CT. Radiology. 2013, 266(1): 326-336CrossRef
14.
go back to reference Skogen K, Ganeshan B, Good C, et al. Measurements of heterogeneity in gliomas on computed tomography relationship to tumour grade. J Neurooncol. 2013, 111(2): 213-219CrossRef Skogen K, Ganeshan B, Good C, et al. Measurements of heterogeneity in gliomas on computed tomography relationship to tumour grade. J Neurooncol. 2013, 111(2): 213-219CrossRef
15.
go back to reference Dworak O, Keilholz L and Hoffmann A. Pathological features of rectal cancer after preoperative radiochemotherapy. Int J Colorectal Dis. 1997, 12(1): 19-23CrossRef Dworak O, Keilholz L and Hoffmann A. Pathological features of rectal cancer after preoperative radiochemotherapy. Int J Colorectal Dis. 1997, 12(1): 19-23CrossRef
16.
go back to reference Vignati A, Mazzetti S, Giannini V, et al. Texture features on T2-weighted magnetic resonance imaging: new potential biomarkers for prostate cancer aggressiveness. Phys Med Biol 2015;60:2685–2701CrossRef Vignati A, Mazzetti S, Giannini V, et al. Texture features on T2-weighted magnetic resonance imaging: new potential biomarkers for prostate cancer aggressiveness. Phys Med Biol 2015;60:2685–2701CrossRef
17.
go back to reference Chee CG, Kim YH, Lee KH,et al.CT texture analysis in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy: A potential imaging biomarker for treatment response and prognosis. PLoS One. 2017,12(8):e0182883 Chee CG, Kim YH, Lee KH,et al.CT texture analysis in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy: A potential imaging biomarker for treatment response and prognosis. PLoS One. 2017,12(8):e0182883
18.
go back to reference Liu L, Liu Y, Xu L,et al.Application of texture analysis based on apparent diffusion coefficient maps in discriminating different stages of rectal cancer.J Magn Reson Imaging. 2017, 45(6):1798-1808 Liu L, Liu Y, Xu L,et al.Application of texture analysis based on apparent diffusion coefficient maps in discriminating different stages of rectal cancer.J Magn Reson Imaging. 2017, 45(6):1798-1808
19.
go back to reference Hunter C, Siddiqui M, Georgiou Delisle T, et al. CT and 3-T MRI accurately identify T3c disease in colon cancer, which strongly predicts disease-free survival. Clin Radiol. 2017, 72(4):307-315CrossRef Hunter C, Siddiqui M, Georgiou Delisle T, et al. CT and 3-T MRI accurately identify T3c disease in colon cancer, which strongly predicts disease-free survival. Clin Radiol. 2017, 72(4):307-315CrossRef
20.
go back to reference Davnall F, Yip CS, Ljungqvist G, et al. Assessment of tumor heterogeneity:an emerging imaging tool for clinical practice? Insights Imaging. 2012, 3(6): 573-589CrossRef Davnall F, Yip CS, Ljungqvist G, et al. Assessment of tumor heterogeneity:an emerging imaging tool for clinical practice? Insights Imaging. 2012, 3(6): 573-589CrossRef
21.
go back to reference De Cecco CN, Ciolina M, Caruso D, et al.Performance of diffusion-weighted imaging, perfusion imaging, and texture analysis in predicting tumoral response to neoadjuvant chemoradiotherapy in rectal cancer patients studied with 3T MR: initial experience. Abdom Radiol (NY). 2016, 41(9): 1728-35CrossRef De Cecco CN, Ciolina M, Caruso D, et al.Performance of diffusion-weighted imaging, perfusion imaging, and texture analysis in predicting tumoral response to neoadjuvant chemoradiotherapy in rectal cancer patients studied with 3T MR: initial experience. Abdom Radiol (NY). 2016, 41(9): 1728-35CrossRef
22.
go back to reference Alobaidli S, McQuaid S, South C, et al. The role of texture analysis in imaging as an outcome predictor and potential tool in radiotherapy treatment planning. Br J Radiol. 2014, 87(1042): 20140369CrossRef Alobaidli S, McQuaid S, South C, et al. The role of texture analysis in imaging as an outcome predictor and potential tool in radiotherapy treatment planning. Br J Radiol. 2014, 87(1042): 20140369CrossRef
23.
go back to reference De Cecco CN, Ganeshan B, Ciolina M, et al. Texture analysis as imaging biomarker of tumoral response to neoadjuvant chemoradiotherapy in rectal cancer patients studied with 3-T magnetic resonance. Investigative radiology. 2015, 50(4): 239-245CrossRef De Cecco CN, Ganeshan B, Ciolina M, et al. Texture analysis as imaging biomarker of tumoral response to neoadjuvant chemoradiotherapy in rectal cancer patients studied with 3-T magnetic resonance. Investigative radiology. 2015, 50(4): 239-245CrossRef
24.
go back to reference Hegde JV, Mulkern RV, Panych LP et al. Multiparametric MRI of prostate cancer: an update on state-of-the-art techniques and their performance in detecting and localizing prostate cancer. J Magn Reson Imaging. 2013, 37: 1035-1054CrossRef Hegde JV, Mulkern RV, Panych LP et al. Multiparametric MRI of prostate cancer: an update on state-of-the-art techniques and their performance in detecting and localizing prostate cancer. J Magn Reson Imaging. 2013, 37: 1035-1054CrossRef
25.
go back to reference Ahmed A, Gibbs P, Pickles M, Turnbull L. Texture analysis in assessment and prediction of chemotherapy response in breast cancer. J Magn Reson Imaging. 2013, 38(1): 89-101CrossRef Ahmed A, Gibbs P, Pickles M, Turnbull L. Texture analysis in assessment and prediction of chemotherapy response in breast cancer. J Magn Reson Imaging. 2013, 38(1): 89-101CrossRef
26.
go back to reference Miles KA, Ganeshan B, Hayball MP. CT texture analysis using the filtration histogram method: what do the measurements mean? Cancer Imaging. 2013, 13(3): 400-406CrossRef Miles KA, Ganeshan B, Hayball MP. CT texture analysis using the filtration histogram method: what do the measurements mean? Cancer Imaging. 2013, 13(3): 400-406CrossRef
27.
go back to reference Duvauferrier R, Bezy J, Bertaud V, et al. Texture analysis software: integration with a radiological workstation. Stud Health Technol Inform. 2012, 180: 1030-1034PubMed Duvauferrier R, Bezy J, Bertaud V, et al. Texture analysis software: integration with a radiological workstation. Stud Health Technol Inform. 2012, 180: 1030-1034PubMed
28.
go back to reference Liu L, Liu Y, Xu L, et al. Application of Texture Analysis Based on Apparent Diffusion Coefficient Maps in Discriminating Different Stages of Rectal Cancer. J Magn Reson Imaging. 2017, 45(6): 1798-1808CrossRef Liu L, Liu Y, Xu L, et al. Application of Texture Analysis Based on Apparent Diffusion Coefficient Maps in Discriminating Different Stages of Rectal Cancer. J Magn Reson Imaging. 2017, 45(6): 1798-1808CrossRef
29.
go back to reference Wang G, He L, Yuan C,et al. Pretreatment MR imaging radiomics signatures for response prediction to induction chemotherapy in patients with nasopharyngeal carcinoma. Eur J Radiol. 2018, 98: 100-106CrossRef Wang G, He L, Yuan C,et al. Pretreatment MR imaging radiomics signatures for response prediction to induction chemotherapy in patients with nasopharyngeal carcinoma. Eur J Radiol. 2018, 98: 100-106CrossRef
Metadata
Title
Prediction of efficacy of neoadjuvant chemoradiotherapy for rectal cancer: the value of texture analysis of magnetic resonance images
Authors
Zhenyu Shu
Songhua Fang
Qin Ye
Dewang Mao
Hongfeng Cao
Peipei Pang
Xiangyang Gong
Publication date
01-11-2019
Publisher
Springer US
Published in
Abdominal Radiology / Issue 11/2019
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-019-01971-y

Other articles of this Issue 11/2019

Abdominal Radiology 11/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.